EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer.
Ye F, Yuan X, Yu W, Ma Y, Mao C, Li X, Li J, Dai C, Qian F, Li J, Fan X, Zhou Y, Dai D, Wang D, Chen D, Xia S, Zhang M.
Ye F, et al. Among authors: li j, li x.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241273198. doi: 10.1177/15330338241273198.
Technol Cancer Res Treat. 2024.
PMID: 39166278
Free PMC article.
Clinical Trial.